Issue navigation
Volume 1, Issue Supplement_1, August 2019
Abstracts from the Society for Neuro-Oncology Inaugural Conference on Brain Metastases August 16 – 17, 2019
Abstracts
Basic Science
BSCI-01. ACTIVATION OF c-Met/β1-INTEGRIN COMPLEX RESULTS IN INCREASE OF MESENCHYMAL GENE EXPRESSION AND STEM CELL POPULATION IN METASTATIC BREAST CANCER TO THE BRAIN AND SPINE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i1, https://doi.org/10.1093/noajnl/vdz014.000
BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i1, https://doi.org/10.1093/noajnl/vdz014.001
BSCI-03. T CELL EXHAUSTION SIGNATURES VARY BY TUMOR TYPE AND ARE INDEPENDENT OF INTRACRANIAL LOCATION
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i1, https://doi.org/10.1093/noajnl/vdz014.002
BSCI-04. TARGETING TRIPLE-NEGATIVE BREAST CANCER BRAIN METASTASES WITH A RE-ENGINEERED LUPUS AUTOANTIBODY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i1–i2, https://doi.org/10.1093/noajnl/vdz014.003
BSCI-05. HOW MICROGLIA, BRAIN RESIDENT MYELOID CELLS, RESPOND TO BREAST CANCER METASTASIS INTO THE BRAIN?
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i2, https://doi.org/10.1093/noajnl/vdz014.004
BSCI-06. FREQUENCY OF BRAIN METASTASIS FROM BREAST AND LUNG CANCER IN THE UNITED STATES -- A POPULATION-BASED ASSESSMENT
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i2, https://doi.org/10.1093/noajnl/vdz014.005
BSCI-07. BONE MARROW T-CELL SEQUESTRATION IN THE SETTING OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i2, https://doi.org/10.1093/noajnl/vdz014.006
BSCI-09. MECHANISMS OF ENHANCED DRUG DELIVERY IN BRAIN METASTASES WITH FOCUSED ULTRASOUND-INDUCED BLOOD-TUMOR BARRIER DISRUPTION
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i2, https://doi.org/10.1093/noajnl/vdz014.007
BSCI-10. NEUROLOGICAL DYSFUNCTION CAUSED BY BRAIN TUMOR-GENERATED SOLID STRESS IS REVERSED BY LITHIUM
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i2–i3, https://doi.org/10.1093/noajnl/vdz014.008
BSCI-11. STROMAL PLATELET DERIVED GROWTH FACTOR RECEPTOR-β (PDGFRβ) PROMOTES BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i3, https://doi.org/10.1093/noajnl/vdz014.009
BSCI-12. COMPREHENSIVE GENOMIC ANALYSIS OF BRAIN METASTASES FROM MULTIPLE CANCER TYPES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i3, https://doi.org/10.1093/noajnl/vdz014.010
BSCI-13. TUMOR-SPECIFIC tGLI1 TRANSCRIPTION FACTOR MEDIATES BREAST CANCER BRAIN METASTASIS VIA ACTIVATING METASTASIS-INITIATING CANCER STEM CELLS AND ASTROCYTES IN THE TUMOR MICROENVIRONMENT
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i3, https://doi.org/10.1093/noajnl/vdz014.011
BSCI-14. SYNTHETIC METASTATIC BRAIN DISEASE MRI IMAGES CREATED USING A GENERATIVE ADVERSARY NETWORK TO OVERCOME DEEP MACHINE LEARNING CHALLENGES IN HEALTHCARE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i3–i4, https://doi.org/10.1093/noajnl/vdz014.012
BSCI-15. METASTATIC BRAIN TUMOR TARGETING PEPTIDES ISOLATED THROUGH PHAGE DISPLAY BIOPANNING AGAINST BRAIN METASTASIS-INITIATING CELLS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i4, https://doi.org/10.1093/noajnl/vdz014.013
BSCI-16. HEMODYNAMIC SHEAR STRESS SELECTS A SUBPOPULATION OF LUNG ADENOCARCINOMA CELLS WITH HIGHER METASTATIC CAPACITY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i4, https://doi.org/10.1093/noajnl/vdz014.014
BSCI-17. YOUNG AGE PROMOTES BREAST CANCER METASTASIS TO THE BRAIN
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i4, https://doi.org/10.1093/noajnl/vdz014.015
BSCI-18. ABLATION OF Csf2 MITIGATES RADIATION-INDUCED NEUROCOGNITIVE DECLINE INDEPENDENT OF HIPPOCAMPAL NEUROGENESIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i4, https://doi.org/10.1093/noajnl/vdz014.016
BSCI-19. EFFECT OF STEREOTACTIC RADIOSURGERY ON NON-SMALL CELL LUNG CANCER BRAIN METASTASIS: CORRELATIVE RADIOBIOLOGIC ANALYSIS FROM PHASE-II CLINICAL TRIAL NCT03398694
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i4–i5, https://doi.org/10.1093/noajnl/vdz014.017
BSCI-20. THERAPEUTIC TARGETING OF HLA-G IN BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i5, https://doi.org/10.1093/noajnl/vdz014.018
BSCI-22. IDENTIFICATION OF ACTIONABLE TYROSINE KINASE-REGULATED NETWORKS REQUIRED FOR LUNG AND BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i5, https://doi.org/10.1093/noajnl/vdz014.019
BSCI-23. TISSUE FACTOR SIGNALING ENHANCES METASTATIC BRAIN CANCER MALIGNANCY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i5, https://doi.org/10.1093/noajnl/vdz014.020
BSCI-25. THE ROLE OF THE IFNγ PATHWAY IN BREAST CANCER BRAIN METASTASIS FORMATION
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i5, https://doi.org/10.1093/noajnl/vdz014.021
BSCI-26. COMPARATIVE METHYLATION PROFILING OF EGFR MUTANT LUNG ADENOCARCINOMA AND PAIRED BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i5–i6, https://doi.org/10.1093/noajnl/vdz014.022
BSCI-27. MELATONIN REDUCES MALIGNANCY OF BREAST CANCER BRAIN METASTATIC CELLS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i6, https://doi.org/10.1093/noajnl/vdz014.023
Leptomeningeal Disease
LPTO-01. LEPTOMENINGEAL METASTASIS FROM OVARIAN CARCINOMA TREATED WITH SYSTEMIC HIGH-DOSE METHOTREXATE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i6, https://doi.org/10.1093/noajnl/vdz014.024
LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i6, https://doi.org/10.1093/noajnl/vdz014.025
LPTO-03. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i6–i7, https://doi.org/10.1093/noajnl/vdz014.026
LPTO-04. GENERATION AND CHARACTERIZATION OF PATIENT-DERIVED PRECLINICAL MODELS FROM TUMOR CELLS ISOLATED FROM CEREBROSPINAL FLUID
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i7, https://doi.org/10.1093/noajnl/vdz014.027
LPTO-05. FACTORS INFLUENCING RISK OF LEPTOMENINGEAL METASTASIS IN BREAST CANCER PATIENTS RECEIVING STEREOTACTIC RADIOSURGERY FOR LIMITED BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i7, https://doi.org/10.1093/noajnl/vdz014.028
LPTO-06. A NOVEL BRAIN-PERMEANT CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i7, https://doi.org/10.1093/noajnl/vdz014.029
LPTO-07. CARCINOEMBRYONIC ANTIGEN OF CEREBROSPINAL FLUID PREDICT PROGNOSIS OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i7, https://doi.org/10.1093/noajnl/vdz014.030
LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i7–i8, https://doi.org/10.1093/noajnl/vdz014.031
LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i8, https://doi.org/10.1093/noajnl/vdz014.032
LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i8, https://doi.org/10.1093/noajnl/vdz014.033
Clinical Trials
TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i8, https://doi.org/10.1093/noajnl/vdz014.034
TRLS-02. A PILOT STUDY OF EVALUATING EARLY TREATMENT RESPONSE OF BRAIN METASTASES AFTER STEREOTACTIC RADIOSURGERY USING DYNAMIC SUSCEPTIBILITY-WEIGHTED PERFUSION MAGNETIC RESONANCE IMAGING
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i8–i9, https://doi.org/10.1093/noajnl/vdz014.035
TRLS-03. PHASE II TRIAL OF GDC-0084 IN COMBINATION WITH TRASTUZUMAB FOR PATIENTS WITH HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BCBM)
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i9, https://doi.org/10.1093/noajnl/vdz014.036
TRLS-04. NEAR INFRARED FLUORESCENT DYE LOCALIZES BRAIN METASTASIS PRIOR TO DURAL OPENING AND IS MORE SENSITIVE THAN WHITE LIGHT IN BRAIN METASTASIS SURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i9, https://doi.org/10.1093/noajnl/vdz014.037
TRLS-05. EARLY RESULTS FROM A PROSPECTIVE PHASE I/II DOSE ESCALATION STUDY OF NEOADJUVANT RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i9, https://doi.org/10.1093/noajnl/vdz014.038
TRLS-06. PHASE 1 EXPANSION STUDY OF IRINOTECAN LIPOSOME INJECTION (nal-IRI) IN PATIENTS WITH METASTATIC BREAST CANCER (mBC): FINDINGS FROM THE COHORT WITH ACTIVE BRAIN METASTASIS (BM)
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i9, https://doi.org/10.1093/noajnl/vdz014.039
TRLS-07. BRAINSTORM: OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I/II STUDY OF RRx-001 IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i9–i10, https://doi.org/10.1093/noajnl/vdz014.040
TRLS-08. CNS PENETRATION AND PRELIMINARY EFFICACY OF SACUTIZUMAB GOVITECAN IN BREAST BRAIN METASTASIS AND GLIOBLASTOMA: A SURGICAL STUDY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i10, https://doi.org/10.1093/noajnl/vdz014.041
TRLS-09. RTOG1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY IN COMBINATION WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASIS FROM HER2-POSITIVE BREAST CANCER
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i10, https://doi.org/10.1093/noajnl/vdz014.042
TRLS-10. MITIGATING NEUROCOGNITIVE DEFICITS FROM WHOLE-BRAIN RADIOTHERAPY IN PATIENTS WITH NUMEROUS BRAIN METASTASES VIA A NOVEL SUPEROXIDE DISMUTASE MIMETIC: RATIONALE & DESIGN OF A CLINICAL TRIAL
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i10, https://doi.org/10.1093/noajnl/vdz014.043
Medical Therapy (Chemotherapy, Targeted Therapy/Immunotherapy)
THER-01. PRECLINICAL DEVELOPMENT OF EO1001, A NOVEL IRREVERSIBLE BRAIN PENETRATING PAN-ErbB INHIBITOR
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i10–i11, https://doi.org/10.1093/noajnl/vdz014.044
THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i11, https://doi.org/10.1093/noajnl/vdz014.045
THER-03. USING SUCCESSIVE EGF RECEPTOR ANTAGONISTS TO TREAT A PATIENT WITH EXTENSIVE METASTATIC DISEASE: CASE REPORT AND REVIEW OF THE LITERATURE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i11, https://doi.org/10.1093/noajnl/vdz014.046
THER-04. THE USE OF AN ADENOSINE A2 AGONIST TO IMPROVE THE PREVENTION AND TREATMENT OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i11, https://doi.org/10.1093/noajnl/vdz014.047
THER-05. SOLITARY CEREBRAL METASTASIS FROM TRANSITIONAL CELL CARCINOMA OF THE BLADDER
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i11, https://doi.org/10.1093/noajnl/vdz014.048
THER-06. GENOMIC AND IMMUNE CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i11–i12, https://doi.org/10.1093/noajnl/vdz014.049
THER-07. DEVELOPMENT OF A NEW MOLECULAR PREDICTOR FOR RISK OF BRAIN METASTASES AND EFFICACY OF TARGETED THERAPY IN MELANOMA
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i12, https://doi.org/10.1093/noajnl/vdz014.050
THER-08. BRAIN METASTASES AS A FIRST SITE OF RECURRENCE IN PATIENTS RECEIVING CHEMOTHERAPY WITH CONTROLLED SYSTEMIC CANCER: A CRITICAL BUT UNDER-RECOGNIZED CLINICAL SCENARIO
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i12, https://doi.org/10.1093/noajnl/vdz014.051
THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i12, https://doi.org/10.1093/noajnl/vdz014.052
THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i12–i13, https://doi.org/10.1093/noajnl/vdz014.053
THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.054
THER-12. PRECLINICAL EVALUATION OF NERATINIB PLUS T-DM1 IN ORTHOTOPIC PDX MODELS OF HER2-POSITIVE BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.055
THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.056
THER-14. INFLUENCE OF CLINICAL PARAMETERS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES (NSCLCBM)
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.057
THER-15. DEVELOPING TUMOR-HOMING CYTOTOXIC HUMAN INDUCED NEURAL STEM CELL THERAPY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i13–i14, https://doi.org/10.1093/noajnl/vdz014.058
THER-16. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i14, https://doi.org/10.1093/noajnl/vdz014.059
Multimodality
MLTI-01. IMMUNOLOGICAL REPROGRAMMING IN THE CNS TUMOR MICROENVIRONMENT AND THERAPEUTIC EFFICACY OF RADIOTHERAPY WITH STAT3 BLOCKADE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i14, https://doi.org/10.1093/noajnl/vdz014.060
MLTI-02. A PHASE I TRIAL OF SORAFENIB WITH WHOLE BRAIN RADIOTHERAPY (WBRT) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES AND A CORRELATIVE FLT-PET BRAIN IMAGING STUDY IN PATIENTS RECEIVING WBRT +/- SORAFENIB
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i14, https://doi.org/10.1093/noajnl/vdz014.061
MLTI-03. FIRST-LINE STEREOTACTIC RADIOSURGERY COMBINED WITH SYSTEMIC TARGETED AND IMMUNE CHECKPOINT INHIBITOR THERAPY IN MELANOMA PATIENTS WITH NEWLY DIAGNOSED BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i14–i15, https://doi.org/10.1093/noajnl/vdz014.062
MLTI-04. EVOLUTION OF TREATMENT PARADIGMS FOR PATIENTS WITH ≥1 BRAIN METASTASES FROM PRIMARY NON-SMALL-CELL LUNG CANCER – A SYSTEMATIC REVIEW
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i15, https://doi.org/10.1093/noajnl/vdz014.063
MLTI-05. IDENTIFYING BRAIN METASTATIC CASES FROM FREE TEXT CLINICAL NARRATIVES WITH REFINEMENT OF SEMANTIC HETEROGENEITY USING MACHINE LEARNING
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i15, https://doi.org/10.1093/noajnl/vdz014.064
MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i15, https://doi.org/10.1093/noajnl/vdz014.065
MLTI-07. PREOPERATIVE VERSUS POSTOPERATIVE STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES: AN INTERNATIONAL META-ANALYSIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i15–i16, https://doi.org/10.1093/noajnl/vdz014.066
MLTI-08. AN EXCEPTIONAL INTRACRANIAL RESPONSE TO REPEAT RADIATION AND IMMUNOTHERAPY IN A PATIENT WITH METASTATIC, POORLY DIFFERENTIATED ADENOCARCINOMA OF THE LUNG
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i16, https://doi.org/10.1093/noajnl/vdz014.067
MLTI-09. UNDERWEIGHT AND WEIGHT LOSS ARE PREDICTORS OF POOR OUTCOME IN PATIENTS WITH BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i16, https://doi.org/10.1093/noajnl/vdz014.068
MLTI-10. ESTABLISHMENT OF A MULTIDISCIPLINARY BRAIN METASTASIS CLINIC TO FACILITATE PATIENT-CENTERED CARE AND COORDINATED RESEARCH
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i16, https://doi.org/10.1093/noajnl/vdz014.069
MLTI-11. IMPLANTABLE POLYMERIC BCNU AS AN ADJUNCT TO SURGERY FOR METASTATIC INTRACRANIAL DISEASE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i16, https://doi.org/10.1093/noajnl/vdz014.070
MLTI-12. TIMING OF SYSTEMIC THERAPY ADMINISTRATION RELATIVE TO STEREOTACTIC RADIOSURGERY AND DEVELOPMENT OF RADIATION NECROSIS IN PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i16–i17, https://doi.org/10.1093/noajnl/vdz014.071
MLTI-13. RESPONSE ASSESSMENT OF MELANOMA BRAIN METASTASES TREATED BY STEREOTACTIC RADIOTHERAPY OR IMMUNOTHERAPY OR BOTH: A COMPARISON OF RECIST 1.1, RANO AND iRANO CRITERIA
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i17, https://doi.org/10.1093/noajnl/vdz014.072
MLTI-14. A SYSTEMATIC REVIEW OF TREATMENT PARADIGMS FOR PATIENTS WITH BREAST CANCER AND ONE OR MORE BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i17, https://doi.org/10.1093/noajnl/vdz014.073
MLTI-15. A CASE SERIES OF PRE-OPERATIVE GAMMA-KNIFE RADIOSURGERY FOR RESECTABLE BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i17, https://doi.org/10.1093/noajnl/vdz014.074
MLTI-16. SYSTEMIC THERAPY FOLLOWING CRANIOTOMY IN PATIENTS WITH A SOLITARY BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i17, https://doi.org/10.1093/noajnl/vdz014.075
MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i17–i18, https://doi.org/10.1093/noajnl/vdz014.076
MLTI-18. PRECISION IMAGING OF METASTATIC AND PRIMARY BRAIN TUMORS AFTER RADIATION WITH 18F-FDOPA PET-MRI IS FEASIBLE AND COST EFFECT
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i18, https://doi.org/10.1093/noajnl/vdz014.077
MLTI-19. VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH BRAIN METASTASES: THE PICOS SCORE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i18, https://doi.org/10.1093/noajnl/vdz014.078
Other
OTHR-01. USING COGNITION TO PREDICT RISK OF MEDICAL DECISION-MAKING IMPAIRMENT IN BRAIN CANCER
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i18, https://doi.org/10.1093/noajnl/vdz014.079
OTHR-03. ENHANCEMENT OF T1W-GAD MRI IS ASSOCIATED WITH POST-SRS LOCAL CONTROL OF NSCLC BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i18, https://doi.org/10.1093/noajnl/vdz014.080
OTHR-04. INCIDENCE AND SURVIVAL OUTCOMES IN UROTHELIAL CARCINOMA BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i18–i19, https://doi.org/10.1093/noajnl/vdz014.081
OTHR-05. THE ABILITY TO MAKE INFORMED TREATMENT DECISIONS IS COMPROMISED IN ADULTS WITH ADVANCED STAGE CANCER
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i19, https://doi.org/10.1093/noajnl/vdz014.082
OTHR-06. ANALYSIS OF GENOMIC ALTERATIONS IN 154 BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i19, https://doi.org/10.1093/noajnl/vdz014.083
OTHR-07. ESTIMATING INCIDENCE PROPORTION OF BRAIN METASTASES AT DIAGNOSIS AND LIFETIME INCIDENCE AMONG CANCER PATIENTS DIAGNOSED FROM 2010–2015 IN CANADA
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i19, https://doi.org/10.1093/noajnl/vdz014.084
OTHR-08. PREDICTION OF RISK OF CENTRAL NERVOUS SYSTEM METASTASIS FOR AJCC 8TH EDITION STAGE III MELANOMA PATIENTS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i19–i20, https://doi.org/10.1093/noajnl/vdz014.085
OTHR-09. IDENTIFYING EPIGENETIC SIGNATURES IN LUNG ADENOCARCINOMAS THAT PREDICT DEVELOPMENT OF BRAIN METASTASIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i20, https://doi.org/10.1093/noajnl/vdz014.086
OTHR-10. THE NATIONAL DISTRIBUTION OF NEWLY-DIAGNOSED BRAIN METASTASES IN ADULTS VARIES WIDELY BY PATIENT DEMOGRAPHICS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i20, https://doi.org/10.1093/noajnl/vdz014.087
OTHR-11. TUMOR RELATED IMPAIRMENTS OF NEUROCOGNITIVE FUNCTIONS IN PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i20, https://doi.org/10.1093/noajnl/vdz014.088
OTHR-12. DRIVING RECOMMENDATIONS IN PATIENTS WITH NEWLY DIAGNOSED BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i20, https://doi.org/10.1093/noajnl/vdz014.089
OTHR-13. A DEEP LEARNING APPROACH TO DETECT CANCER METASTASES TO THE BRAIN IN MRI
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i20–i21, https://doi.org/10.1093/noajnl/vdz014.090
OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i21, https://doi.org/10.1093/noajnl/vdz014.091
OTHR-15. PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER THAT RECUR WITH ISOLATED BRAIN METASTASES HAVE PROLONGED SURVIVAL
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i21, https://doi.org/10.1093/noajnl/vdz014.092
OTHR-16. MOLECULAR PROFILING USING THE 92-GENE ASSAY FOR TUMOR CLASSIFICATION OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i21, https://doi.org/10.1093/noajnl/vdz014.093
OTHR-17. PHYLOGENETIC RESOLUTION OF TISSUE-SPECIFIC METASTOGENIC CLONES IN RENAL CELL CARCINOMA
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i21, https://doi.org/10.1093/noajnl/vdz014.094
Radiation
RADI-01. PROGNOSTIC FACTORS OF SHORT SURVIVAL FOR BRAIN METASTASES TREATED WITH SRS WITHOUT WBRT.
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i21–i22, https://doi.org/10.1093/noajnl/vdz014.095
RADI-02. SINGLE-SESSION VERSUS MULTISESSION GAMMA KNIFE RADIOSURGERY FOR LARGE BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER: RETROSPECTIVE ANALYSIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i22, https://doi.org/10.1093/noajnl/vdz014.096
RADI-04. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i22, https://doi.org/10.1093/noajnl/vdz014.097
RADI-05. FRACTIONATED TREATMENT OF BRAIN METASTASES WITH GAMMA KNIFE ICON
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i22, https://doi.org/10.1093/noajnl/vdz014.098
RADI-06. SINGLE- VERSUS MULTI-FRACTION STEREOTACTIC RADIOSURGERY FOR BRAINSTEM METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i22–i23, https://doi.org/10.1093/noajnl/vdz014.099
RADI-07. GAMMA KNIFE RADIOSURGERY FOR SMALL CELL LUNG CANCER: PROGNOSTIC FACTORS INCLUDING ADDITIONAL LESIONS IDENTIFIED ON THE DAY OF RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i23, https://doi.org/10.1093/noajnl/vdz014.100
RADI-08. A SURVEY BASED STUDY OF BRAIN METASTASES MANAGEMENT FOR PATIENTS WITH NON-SMALL CELL LUNG CANCERS OR MELANOMA
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i23, https://doi.org/10.1093/noajnl/vdz014.101
RADI-09. DEFINING PROGRESSION IN PATIENTS TREATED WITH TEN OR MORE BRAIN METASTASES FOLLOWING STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i23, https://doi.org/10.1093/noajnl/vdz014.102
RADI-10. THERAPEUTIC EFFECTS OF fSRS IN 44 CASES OF BRAIN METASTASES OF NSCLC WITH A MAXIMUM DIAMETER ≥ 4CM AND ANALYSIS OF ITS PROGNOSTIC FACTORS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i23, https://doi.org/10.1093/noajnl/vdz014.103
RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM)
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i23–i24, https://doi.org/10.1093/noajnl/vdz014.104
RADI-12. LEPTOMENINGEAL FAILURE AFTER PREOPERATIVE VERSUS POSTOPERATIVE RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i24, https://doi.org/10.1093/noajnl/vdz014.105
RADI-13. IMPACT OF CITV AND BRAF MUTATION ON MELANOMA METASTASIS RESPONSE TO STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i24, https://doi.org/10.1093/noajnl/vdz014.106
RADI-14. FRAMELESS STEREOTACTIC RADIOSURGERY ON THE GAMMA KNIFE ICON: EARLY EXPERIENCE FROM 42 PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i24, https://doi.org/10.1093/noajnl/vdz014.107
RADI-15. CLUSTERING AND GROUPING OF BRAIN METS IN RADIOSURGERY TREATMENTS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i24, https://doi.org/10.1093/noajnl/vdz014.108
RADI-16. ECONOMIC IMPLICATIONS OF PREOPERATIVE VERSUS POSTOPERATIVE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i24–i25, https://doi.org/10.1093/noajnl/vdz014.109
RADI-18. STEREOTACTIC RADIOSURGERY OR FRACTIONATED STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM SMALL CELL LUNG CANCER
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i25, https://doi.org/10.1093/noajnl/vdz014.110
RADI-19. EVALUATION OF BRAIN METASTASIS LOCAL CONTROL POST RADIOSURGERY VIA MACHINE LEARNING AND RADIOMICS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i25, https://doi.org/10.1093/noajnl/vdz014.111
RADI-20. RETROSPECTIVE OUTCOME ANALYSIS OF INTRAOPERATIVE RADIOTHERAPY (IORT) FOR SURGICALLY RESECTED BRAIN METASTASES: AN INTERNATIONAL COOPERATIVE STUDY.
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i25, https://doi.org/10.1093/noajnl/vdz014.112
RADI-21. STEREOTACTIC RADIOSURGERY FOR 10 OR MORE BRAIN METASTASES PROVIDES EXCELLENT RATES OF INTRACRANIAL DISEASE CONTROL WITH SUPERIOR HIPPOCAMPAL SPARING
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i25–i26, https://doi.org/10.1093/noajnl/vdz014.113
RADI-22. CHARACTERIZING CLINICAL SURVIVAL PATTERNS USING MACHINE LEARNING: AN ANALYSIS OF BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i26, https://doi.org/10.1093/noajnl/vdz014.114
RADI-23. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR RECURRENCE FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i26, https://doi.org/10.1093/noajnl/vdz014.115
RADI-24. VENTRICULOMEGALY AFTER STEREOTACTIC RADIOSURGERY (SRS) FOR BRAIN METASTASES (BM): A PILOT ANALYSIS OF TWO INSTITUTIONAL EXPERIENCES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i26, https://doi.org/10.1093/noajnl/vdz014.116
RADI-25. REPEAT STEREOTACTIC RADIOSURGERY FOR RECURRENT BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i26, https://doi.org/10.1093/noajnl/vdz014.117
RADI-26. DOSIMETRIC EVALUATION OF 6 MV VERSUS 10 MV PHOTONS FOR HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i26–i27, https://doi.org/10.1093/noajnl/vdz014.118
RADI-27. ROLE OF STEREOTACTIC RADIOSURGERY IN THE CARE OF PATIENTS WITH >/= 25 CUMULATIVE BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i27, https://doi.org/10.1093/noajnl/vdz014.119
RADI-28. UP-FRONT SINGLE SESSION RADIOSURGERY FOR LARGE BRAIN METASTASES - VOLUMETRIC RESPONSES AND OUTCOMES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i27, https://doi.org/10.1093/noajnl/vdz014.120
RADI-29. BIOLOGIC SUBTYPES OF BREAST CANCER BRAIN METS AS A PREDICTOR OF LOCAL CONTROL AFTER STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i27, https://doi.org/10.1093/noajnl/vdz014.121
RADI-30. TREATMENT OF MULTIPLE BRAIN METASTASES WITH CYBERKNIFE® (CK) INITIAL EXPERIENCE AT THE RADIONCOLOGY DEPARTMENT JÚLIO TEIXEIRA SA – PORTO – PORTUGAL
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i27–i28, https://doi.org/10.1093/noajnl/vdz014.122
RADI-31. MULTI-INSTITUTIONAL VALIDATION OF BRAIN METASTASIS VELOCITY, A RECENTLY DEFINED PREDICTOR OF OUTCOMES FOLLOWING STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i28, https://doi.org/10.1093/noajnl/vdz014.123
RADI-32. INTRACRANIAL CONTROL AND RADIONECROSIS IN MELANOMA PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i28, https://doi.org/10.1093/noajnl/vdz014.124
RADI-33. DISTRIBUTED FRAMELESS GAMMA KNIFE RADIOSURGERY: A NEW TREATMENT PARADIGM FOR PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i28, https://doi.org/10.1093/noajnl/vdz014.125
RADI-34. USE OF LOW-DOSE STEREOTACTIC RADIOSURGERY FOR ADVANCED BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i28, https://doi.org/10.1093/noajnl/vdz014.126
RADI-35. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i28–i29, https://doi.org/10.1093/noajnl/vdz014.127
RADI-36. FRAME-BASED VERSUS FRAMELESS GAMMA KNIFE RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i29, https://doi.org/10.1093/noajnl/vdz014.128
RADI-37. CLINICAL RISK FACTORS FOR INTRACRANIAL HEMORRHAGE OF SOLID MELANOMA BRAIN METASTASES AFTER RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i29, https://doi.org/10.1093/noajnl/vdz014.129
RADI-39. EFFECT OF RIND-BASED DOSIMETRIC TECHNIQUES FOR SCALP DOSE REDUCTION IN BRAIN IRRADIATION
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i29, https://doi.org/10.1093/noajnl/vdz014.130
RADI-40. STEREOTACTIC RADIOSURGERY FOR BRAINSTEM METASTASES: AN ANALYSIS OF SINGLE FRACTION AND MULTI FRACTION TECHNIQUES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i29, https://doi.org/10.1093/noajnl/vdz014.131
RADI-41. CLINICAL OUTCOMES FOLLOWING RAPID DELIVERY SINGLE ISOCENTER RADIOSURGERY FOR FIVE OR MORE BRAIN METASTASES: VOLUMETRIC MODULATED ARC THERAPY VS. DYNAMIC CONFORMAL ARC
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i29–i30, https://doi.org/10.1093/noajnl/vdz014.132
RADI-42. ASSOCIATION BETWEEN TUMOR LOCATION AND TOXICITY OUTCOMES AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i30, https://doi.org/10.1093/noajnl/vdz014.133
RADI-43. ARTERIAL SPIN LABELING PERFUSION MR IMAGING FOR DIFFERENTIATION BETWEEN TUMOR RECURRENCE AND PSEUDOPROGRESSION IN INTRACRANIAL METASTASES FOLLOWING STEREOTACTIC RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i30, https://doi.org/10.1093/noajnl/vdz014.134
RADI-44. MANAGEMENT OF MULTIPLE BRAIN METASTASES BY STAGED SRS FOCUSING ON UTMOST RISK LESIONS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i30, https://doi.org/10.1093/noajnl/vdz014.135
Surgery
SURG-01. LITT FOR IN-FIELD RECURRENCE OF BRAIN METASTASIS AFTER STEREOTACTIC RADIOSURGERY: OUTCOMES AND MECHANISMS OF DEATH
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i30–i31, https://doi.org/10.1093/noajnl/vdz014.136
SURG-02. LASER INTERSTITIAL THERMAL THERAPY FOR BRAIN METASTASES: OUTCOMES AND PREDICTORS OF LOCAL RECURRENCE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i31, https://doi.org/10.1093/noajnl/vdz014.137
SURG-03. SPATIAL COORDINATES FROM GAMMA KNIFE RADIOSURGERY REVEAL PRIMARY CANCERS HAVE REGIONAL CNS TOPOGRAPHICAL DISTRIBUTION FOR BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i31, https://doi.org/10.1093/noajnl/vdz014.138
SURG-04. SIMULTANEOUS CRANIOTOMIES FOR MULTIPLE BRAIN METASTASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i31, https://doi.org/10.1093/noajnl/vdz014.139
SURG-05. LASER INTERSTITIAL THERMAL THERAPY FOR MELANOMA BRAIN METASTASIS: A CASE SERIES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i31, https://doi.org/10.1093/noajnl/vdz014.140
SURG-06. LASER INTERSTITIAL THERMAL THERAPY COMPARED TO CRANIOTOMY FOR TREATMENT OF RADIATION NECROSIS OR RECURRENT TUMOR IN BRAIN METASTASES FAILING RADIOSURGERY
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i31–i32, https://doi.org/10.1093/noajnl/vdz014.141
SURG-07. CORRELATION BETWEEN VOLUMETRIC ANALYSIS AND CLINICAL OUTCOMES OF BRAIN METASTASES TREATED WITH LASER INTERSTITIAL THERMAL THERAPY (LITT)
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i32, https://doi.org/10.1093/noajnl/vdz014.142
SURG-08. GASTROINTESTINAL STROMAL TUMOR WITH INTRACRANIAL METASTASIS: CASE REPORT AND SYSTEMATIC REVIEW OF LITERATURE
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i32, https://doi.org/10.1093/noajnl/vdz014.143
SURG-09. SURGICAL AND PERI-OPERATIVE CONSIDERATIONS FOR BRAIN METASTASES: A NATIONWIDE ANALYSIS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i32, https://doi.org/10.1093/noajnl/vdz014.144
SURG-10. MELANOMA CEREBRAL METASTASES IN IRELAND- GETTING UNDER THE SKIN
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i32, https://doi.org/10.1093/noajnl/vdz014.145
SURG-11. THE ROLE OF MAGNETIC RESONANCE-GUIDED LASER ABLATION FOR INTRACRANIAL METASTATIC TUMORS
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i32–i33, https://doi.org/10.1093/noajnl/vdz014.146
SURG-12. A COMPARISON BETWEEN PROGNOSTIC SCORES OF BREAST CANCER BRAIN METASTASES APPLIED TO A NEUROSURGICAL POPULATION
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i33, https://doi.org/10.1093/noajnl/vdz014.147
SURG-13. EVALUATION OF 5-ALA FLUORESCENCE IN BRAIN METASTASES OF VARIOUS PRIMARY TUMORS: A MULTICENTER STUDY WITH EXPERIENCE IN 157 CASES
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i33, https://doi.org/10.1093/noajnl/vdz014.148
Author Index
Author Index
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i35–i41, https://doi.org/10.1093/noajnl/vdz014
